Recent Updates
Recently added Catalysts
NUS

NU SKIN ENTERPRISES REPORTS FIRST-QUARTER 2020

Key Takeaway: NU SKIN ENTERPRISES REPORTS FIRST-QUARTER 2020 RESULTS PROVO, Utah - May 6, 2020 - Nu Skin Enterprises, Inc. (NYSE: NUS) today announced first-quarter 2020 results above guidance. Q1 2020 vs. Prior-Year Quarter Revenue: $ 518.0 million; (17%) (2%) fx impact or ($14.3) million

Full Press Release Details

NU SKIN ENTERPRISES REPORTS FIRST-QUARTER 2020 RESULTS
PROVO, Utah - May 6, 2020 - Nu Skin Enterprises, Inc. (NYSE: NUS) today announced first-quarter 2020 results above guidance.
Q1 2020 vs. Prior-Year Quarter
Revenue: $ 518.0 million; (17%) (2%) fx impact or ($14.3) million
Earnings Per Share (EPS): $0.36; (53%)
Sales Leaders: 49,551; (22%)
Customers: 1,130,947; (5%)
"The efforts and resiliency of our sales leaders and global teams helped us achieve revenue and earnings above guidance in the first quarter," said Ritch Wood, chief
executive officer. "While COVID-19 continues to present significant challenges globally, we are grateful for the heroic efforts of healthcare workers, first responders and other essential workers around the world. From a Nu Skin perspective, our
entire organization has mobilized to protect the health and safety of our teams and ensure business continuity for our customers. As a result, we have been able to maintain support for our sales leaders, leverage our supply chain to meet consumer
demand for our products and utilize technology to facilitate remote work for both our sales leaders and employees."
"Our first quarter results demonstrated continued stability in the Nu Skin business with strong customer activity. More than 80 percent of our revenue comes through our
digital properties which have been enhanced by our strategic investments in technology infrastructure and digital tools. Additionally, our manufacturing and supply chain investments have enabled us to effectively manage inventory and fulfill customer
orders worldwide through very challenging circumstances. Our manufacturing segment performed well considering the supply chain disruptions related to certain ingredients and packaging materials due to the pandemic. We generated solid cash flow during
the quarter, increased our dividend for the 19th consecutive year and utilized our cash to repurchase shares in a way that we believe will benefit shareholders going forward," continued Wood.
Q1 2020 Year-Over-Year Operating Results
Revenue: $518.0 million compared to $623.6 million (2%) fx impact or ($14.3) million
Gross Margin: 75.7% compared to 76.5% Nu Skin business was 78.1% compared to 78.7%
Selling Expenses: 39.8% of revenue compared to 40.0% Nu Skin business was 42.0% compared to 42.0%
G&A Expenses: 28.9% of revenue compared to 25.4%
Operating Margin: 7.1% compared to 11.0%
Other Income / (Expense): ($6.2) million compared to ($2.8) million ($3.1) million due to fx
Income Tax Rate: 35.1% compared to 34.7%
EPS: $0.36 compared to $0.77
Dividend Payments: $20.7 million
Stock Repurchases: $60.9 million $409.3 million remaining in authorization
Q2 and Full-Year 2020 Outlook
Q2 2020 Revenue: $520 to $550 million; (12 to 17%) Approximately (3 to 4%) fx impact
Q2 2020 EPS: $0.42 to $0.52
2020 Revenue: $2.17 billion to $2.26 billion; (7 to 10%) Approximately (2 to 3%) fx impact
2020 EPS $2.05 to $2.35
"While there is a great deal of uncertainty in the broader economy, we are optimistic our business will perform well as sales leaders leverage our technology investments to
drive product demand and interest in the business opportunity," said Wood. "The situation in Mainland China is stabilizing with the country returning to work, a key development we believe will translate into improvement throughout the year. We
anticipate similar trends in most of our other markets as pandemic restrictions begin to ease elsewhere across the globe. We continue to believe this trend, paired with the global preview of our newest beauty device late in 2020, sets our business up
for a return to growth toward the end of the year," Wood concluded.
Mark Lawrence, chief financial officer, added, "We are encouraged with our first-quarter results, despite the economic challenges. During the quarter, we generated strong
cash from operations and leveraged the strength of our balance sheet to pay an increased dividend and repurchase $61 million of our stock. As we look ahead to the second quarter, our revenue guidance is $520 to $550 million, which includes an
approximate 3 to 4 percent unfavorable foreign currency impact, and an earnings per share outlook of $0.42 to $0.52. Our 2020 revenue guidance of $2.17 to $2.26 billion reflects a negative foreign currency impact of 2 to 3 percent, an increased fx
headwind of more than 1 percent from our previous guidance, and we anticipate annual earnings per share of $2.05 to $2.35."
The Nu Skin management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well
as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available at the same URL through May 20, 2020.
About Nu Skin Enterprises, Inc.
Founded 35 years ago, Nu Skin Enterprises, Inc. (NSE) empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and
life-improving values. The company currently focuses its efforts around innovative consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and
distributes a comprehensive line of premium-quality beauty and wellness solutions through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific; and Rhyz, our strategic investment arm that includes a collection of
sustainable manufacturing and technology innovation companies. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at nuskinenterprises.com.
Important Information Regarding Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations
and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the
company's performance, growth, product launches, benefits to shareholders, strategies and initiatives; statements of management's expectations regarding the future status of the COVID-19 pandemic globally and across the company's markets, and
government and public behavior in response to such status; projections regarding revenue, earnings per share, foreign currency fluctuations and other financial items; statements of belief; and statements of assumptions underlying any of the
foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "continue," "anticipate," "optimistic," "benefit," "project," "outlook," "guidance," "plan," "continue," "will," "would," "could,"
"may," "might," the negative of these words and other similar words.
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially
from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:
The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated
risks set forth in the documents filed by the company with the Securities and Exchange Commission, including the Form 10-K for the fiscal year ending December 31, 2019, the Forms 8-K filed on March 18, 2020 and April 21, 2020, and the Form 10-Q for
the fiscal quarter ending March 31, 2020. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided, and the company assumes no duty to update the forward-looking statements contained in
this release to reflect any change except as required by law.
Non-GAAP Financial Measures: Constant-currency revenue change
is a non-GAAP financial measure that removes the impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the company's performance. It is calculated by translating the current period's revenue
at the same average exchange rates in effect during the applicable prior-year period and then comparing that amount to the prior-year period's revenue. The company believes that constant-currency revenue change is useful to investors, lenders and
analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company's revenue from period to period.
The Company's revenue results by segment for the three-month periods ended March 31 are presented in the following table (in thousands).
Three Months Ended March 31, Constant- Currency
2020 2019 Change Change
Nu Skin
Mainland China $ 137,696 $ 208,488 (34 )% (31 )%
South Korea 75,719 83,853 (10 )% (4 )%
Americas/Pacific 74,573 86,456 (14 )% (9 )%
Southeast Asia 69,586 72,495 (4 )% (3 )%
Japan 61,300 62,109 (1 )% (2 )%
Hong Kong/Taiwan 35,827 40,558 (12 )% (13 )%
EMEA 35,403 41,818 (15 )% (13 )%
Other 773 (1,426 ) 154 % 154 %
Total Nu Skin 490,877 594,351 (17 )% (15 )%
Manufacturing 27,147 29,272 (7 )% (7 )%
Grow Tech 4 - - -
Total $ 518,028 $ 623,623 (17 )% (15 )%
The company's Customers and Sales Leaders statistics by segment for the three-month periods ended March 31 are presented in the following table.
As of March 31, 2020 As of March 31, 2019 % Increase (Decrease)
Customers Sales Leaders Customers Sales Leaders Customers Sales Leaders
Mainland China 271,536 16,159 272,053 26,986 - (40 )%
South Korea 174,004 6,608 181,150 6,671 (4 )% (1 )%
Americas/Pacific 214,139 6,930 242,925 7,862 (12 )% (12 )%
Southeast Asia 145,116 6,634 138,112 7,071 5 % (6 )%
Japan 119,784 5,635 126,526 5,840 (5 )% (4 )%
Hong Kong/Taiwan 66,024 3,348 70,354 3,959 (6 )% (15 )%
EMEA 140,344 4,237 162,086 4,859 (13 )% (13 )%
Total 1,130,947 49,551 1,193,206 63,248 (5 )% (22 )%
NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
(U.S. dollars in thousands, except per share amounts)
Three Months Ended March 31,
2020 2019
Revenue $ 518,028 $ 623,623
Cost of sales 125,793 146,664
Gross profit 392,235 476,959
Operating expenses:
Selling expenses 206,042 249,708
General and administrative expenses 149,628 158,598
Total operating expenses 355,670 408,306
Operating income 36,565 68,653
Other income (expense), net (6,174 ) (2,848 )
Income before provision for income taxes 30,391 65,805
Provision for income taxes 10,661 22,803
Net income $ 19,730 $ 43,002
Net income per share:
Basic $ 0.36 $ 0.78
Diluted $ 0.36 $ 0.77
Weighted-average common shares outstanding (000s):
Basic 55,059 55,436
Diluted 55,101 56,128
NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
(U.S. dollars in thousands)
March 31, 2020 December 31, 2019
ASSETS
Current assets:
Cash and cash equivalents $ 352,578 $ 335,630
Current investments 9,087 8,413
Accounts receivable 43,973 50,378
Inventories, net 257,474 275,891
Prepaid expenses and other 66,457 69,854
Total current assets 729,569 740,166
Property and equipment, net 449,486 453,604
Right-of-use assets 147,678 144,326
Goodwill 196,573 196,573
Other intangible assets, net 77,796 80,321
Other assets 145,217 154,016
Total assets $ 1,746,319 $ 1,769,006
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 39,891 $ 38,979
Accrued expenses 285,213 290,281
Current portion of long-term debt 95,000 27,500
Total current liabilities 420,104 356,760
Operating lease liabilities 108,145 105,701
Long-term debt 327,197 334,461
Other liabilities 90,375 96,795
Total liabilities 945,821 893,717
Stockholders' equity:
Class A common stock 91 91
Additional paid-in capital 557,916 557,544
Treasury stock, at cost (1,384,036 ) (1,324,826 )
Accumulated other comprehensive loss (100,289 ) (85,292 )
Retained earnings 1,726,816 1,727,772
Total stockholders' equity 800,498 875,289
Total liabilities and stockholders' equity $ 1,746,319 $ 1,769,006
Media: media@nuskin.com, (801) 345-6397
Investors: investorrelations@nuskin.com, (801) 345-3577
Last updated: May 6, 2020